Literature DB >> 729610

Clinical and pharmacological investigations of the new saluretic azosemid.

F Krück, W Bablok, E Besenfelder, G Betzien, B Kaufmann.   

Abstract

Ple 1053 (Azosemid) is a diuretic which resembles furosemide chemically and in its mode of action. When administered intravenously, Ple 1053 was approximately 5 times more potent on a weight basis than furosemide, its dose-response relationship was closer and the slope was steeper. After oral administration Ple 1053 and furosemide were approximately equal in potency. However, the effect of Azosemid in healthy subjects was relatively prolonged and abrupt peaks did not occur.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 729610     DOI: 10.1007/bf02089953

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  3 in total

1.  A rapid and precise method for the determination of urea.

Authors:  J K FAWCETT; J E SCOTT
Journal:  J Clin Pathol       Date:  1960-03       Impact factor: 3.411

2.  Microdetermination of plasma phospholipids by trichloroacetic acid precipitation.

Authors:  D B ZILVERSMIT; A K DAVIS
Journal:  J Lab Clin Med       Date:  1950-01

3.  Furosemide concentrations in serum and urine, and its binding by serum proteins as measured fluorometrically.

Authors:  A W Forrey; B Kimpel; A D Blair; R E Cutler
Journal:  Clin Chem       Date:  1974-02       Impact factor: 8.327

  3 in total
  9 in total

1.  Ultrasound Assessment of Kidney Volume in Patients with Acute Decompensated Heart Failure: A Predictor of Diuretic Resistance.

Authors:  Shinobu Sugihara; Yoshiharu Kinugasa; Tomoaki Takata; Takaaki Sugihara; Keiko Hosho; Chitose Imai; Hiromi Ito; Kensaku Yamada; Masahiko Kato; Kazuhiro Yamamoto
Journal:  Yonago Acta Med       Date:  2017-09-15       Impact factor: 1.641

2.  Pharmacokinetics and pharmacodynamics of azosemide after intravenous and oral administration to rats: absorption from various GI segments.

Authors:  S H Lee; M G Lee
Journal:  J Pharmacokinet Biopharm       Date:  1996-12

Review 3.  Diuretics. Clinical pharmacology and therapeutic use (Part I).

Authors:  A Lant
Journal:  Drugs       Date:  1985-01       Impact factor: 9.546

Review 4.  Clinical pharmacokinetics of some newer diuretics.

Authors:  B Beermann; M Grind
Journal:  Clin Pharmacokinet       Date:  1987-10       Impact factor: 6.447

5.  Changes in brain natriuretic peptide in chronic heart failure patients treated with long-acting versus short-acting loop diuretics: J-MELODIC subanalysis.

Authors:  Miho Fukui; Takeshi Tsujino; Shinichi Hirotani; Hiroshi Ito; Kazuhiro Yamamoto; Takashi Akasaka; Yutaka Hirano; Nobuyuki Ohte; Takashi Daimon; Satoshi Nakatani; Masaaki Kawabata; Tohru Masuyama
Journal:  Heart Vessels       Date:  2017-01-19       Impact factor: 2.037

6.  Diuretic activity of torasemide and furosemide in chronic heart failure: a comparative double blind cross-over study.

Authors:  A J Scheen; J C Vancrombreucq; J Delarge; A S Luyckx
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

7.  Worsening of renal function during 1 year after hospital discharge is a strong and independent predictor of all-cause mortality in acute decompensated heart failure.

Authors:  Tomoya Ueda; Rika Kawakami; Yu Sugawara; Sadanori Okada; Taku Nishida; Kenji Onoue; Tsunenari Soeda; Satoshi Okayama; Yukiji Takeda; Makoto Watanabe; Hiroyuki Kawata; Shiro Uemura; Yoshihiko Saito
Journal:  J Am Heart Assoc       Date:  2014-11-04       Impact factor: 5.501

8.  Effects of tolvaptan on urine output in hospitalized heart failure patients with hypoalbuminemia or proteinuria.

Authors:  Koji Takagi; Naoki Sato; Shiro Ishihara; Michiko Sone; Hideo Tokuyama; Kenji Nakama; Toshiya Omote; Arifumi Kikuchi; Masahiro Ishikawa; Kenichi Amitani; Naoto Takahashi; Yuji Maruyama; Hajime Imura; Wataru Shimizu
Journal:  Heart Vessels       Date:  2017-10-23       Impact factor: 2.037

9.  Renoprotection by long-term low-dose tolvaptan in patients with heart failure and hyponatremia.

Authors:  Tatsufumi Oka; Takayuki Hamano; Tomohito Ohtani; Yohei Doi; Karin Shimada; Ayumi Matsumoto; Satoshi Yamaguchi; Nobuhiro Hashimoto; Masamitsu Senda; Yusuke Sakaguchi; Isao Matsui; Kei Nakamoto; Fusako Sera; Shungo Hikoso; Yasushi Sakata; Yoshitaka Isaka
Journal:  ESC Heart Fail       Date:  2021-09-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.